- RecruitingPHASE2
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
This study is testing a new medicine, KT-621, for adults with moderate to severe eosinophilic asthma. We want to see if it's safe, how well it works, and how it acts in the body.
For: Eosinophilic AsthmaUnited States · Germany · Poland - RecruitingPHASE2
A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis
This study is testing a new medicine, KT-621, for adults and teenagers with moderate to severe eczema (atopic dermatitis). We want to see if it's safe, helps reduce eczema symptoms, and how it works in the body. It involves comparing KT-621 to a dummy medicine.
For: Atopic DermatitisUnited States · Australia · Canada